Business
Latest Headlines
Top Stories
Breaking News
Earnings
Biotech
Investors
Stock Alerts
IPOs
M&A
Canadian
UK
Wallstreet Events
- Industry News
- Technology
- Software
- Banking
- Automotive
- Energy
- More
- Drug Approvals
- Clinical Trial Calendar

Economic News
US
Europe
Asia
Global
Economic Calendar
Economic Scorecard

Crypto
Cryptocurrency
Blockchain

Markets
Morning Mkt Analysis
US Commentary
European Commentary
Asian Commentary
Canadian Commentary
Indian Commentary
Commodities
Bonds
Currencies

Politics
US
World
White House
Elections
General News

Forex
FX Top Stories
Currency Analysis
Currency Alerts
Economic Calendar
Economic Scorecard

Health
Coronavirus
COVID-19 Calendar
Diet & Fitness
Cannabis
Kids Health
Men's Health
Women's Health
Cancer News
Drug Development
Mental Health

Slide Shows

Entertainment
Top Stories
- Pop
- Rock
- Classic Rock
- Rap/Hip-Hop
- Country
- Alternative
- Oldies
- All Genre

Content Licensing
Newswires & Feeds
Content Syndication
Digital Signage Services
Radio News Services

Premium
Intelligent Investor
Biotech Investor NEW
Login

Latest News Videos
Free Content
RSS Feeds
Press Releases
Search
Contact Us

Business
Corp. News
- Latest Headlines
- Biotech
- Investors
- Stock Alerts
- IPOs
- M&A
Industry News
- Technology
- Software
- Banking
- Automotive
- Energy
- More
Corp. Calendars
Earnings Calendar
FDA Calendars
- Drug Approvals
- Clinical Trial Calendar
Ratings Changes
Economy
- US
- Europe
- Asia
- Global
- Economic Calendar
- Economic Scorecard
Crypto
- Cryptocurrency
- Blockchain
Markets
Market News
Politics
- US
- World
- White House
- Elections
- General News
Forex
Health
Health News
Slide Shows
Entertainment
Entertainment News
- Top Stories
Music News
- Pop
- Rock
- Classic Rock
- Rap/Hip-Hop
- Country
- Alternative
- Oldies
- All Genre
Content Licensing
Premium
More

Eli Lilly And Co. (LLY)

Lilly's Foundayo Delivers Superior A1C And Weight Loss In Three Pivotal Diabetes Trials 6/8/2026 8:49:24 PM

Lilly's Retatrutide Delivers Landmark Phase 3 Results Across Obesity And Related Conditions 6/8/2026 6:16:35 AM

Lilly's Foundayo Demonstrates Weight Loss Across Menopause Stages 6/7/2026 11:29:19 AM

Lilly’s Foundayo Shows Significant Weight Loss Across Menopause Stages 6/7/2026 11:11:51 AM

Lilly’s Retatrutide Shows Breakthrough Benefits In Obesity And Related Conditions 6/6/2026 9:39:22 PM

Weekly Buzz: PHG, KMDA Win FDA Nod; FULC Halts Pociredir; RMD Closes Noctrix Deal; NVS Paces In IgAN 6/5/2026 10:26:20 AM

Ascidian Therapeutics, Eli Lilly Join Hands To Develop Devastating Kidney Disease Therapies 6/3/2026 8:08:00 AM

Ascidian Therapeutics And Eli Lilly Announce RNA Collaboration For Kidney Disease Therapies 6/3/2026 7:54:18 AM

Lilly Continues Its Acquisition Spree, Inks Two Asia Partnerships Today 6/1/2026 12:21:58 PM

Hanmi Partners With Lilly On Sonefpeglutide Development; Stock Up 6/1/2026 1:26:42 AM

Lilly And Hanmi Pharm Ink Licensing Agreement For Sonefpeglutide 6/1/2026 12:57:46 AM

Hanmi Licenses Sonefpeglutide To Eli Lilly For Development And Commercialization 5/31/2026 11:17:25 PM

Eli Lilly's Retevmo Phase 3 LIBRETTO-432 Cuts Recurrence Risk 83% In RET+ Early-Stage NSCLC 5/31/2026 8:26:50 AM

Eli Lilly’s Retevmo Delivers 83% Risk Reduction In Phase 3 LIBRETTO-432 Trial For RET Fusion-Positive NSCLC 5/31/2026 8:07:09 AM

Weekly Buzz: AZN, JNJ Get FDA Nod; LLY To Acquire Curevo; APGE Advances Zumilokibart 5/29/2026 10:39:40 AM

Lilly To Acquire Curevo To Advance Next-Generation Shingles Prevention 5/26/2026 7:45:46 AM

Lilly Agrees To Acquire Three Companies: Curevo, LimmaTech Biologics And Vaccine Company 5/26/2026 6:49:41 AM

Lilly: VERVE-102 Produces Dose-dependent Lowering Of PCSK9, LDL-C In 1b Heart-2 Trial 5/25/2026 8:59:00 AM

Lilly Reports Positive Phase 1b Results For VERVE-102, A One-Time Gene Editing Therapy To Lower LDL-C 5/25/2026 8:48:15 AM

Lilly Reports Positive Topline Data From Phase III Obesity Study Of Retatrutide 5/21/2026 7:32:20 AM

- 1
- 2
- 3
- 4
- Next »

Copyright © 2026 RTTNews. All rights reserved. By using this site, you agree to the Terms of Service. About Us | Contact Us | Privacy | Sitemap